This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 48/3/453    most recent 01.HYP.0000230664.32874.52v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guo, D.-F. Articles by Inagami, T. Search for Related Content PubMed PubMed Citation Articles by Guo, D.-F. Articles by Inagami, T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB TESTOSTERONE Related Collections Cardio-renal physiology/pathophysiology ACE/Angiotension receptors Gene expression Hypertension - basic studies Hypertrophy Related Article

(Hypertension. 2006;48:453.)
© 2006 American Heart Association, Inc.

Original Articles

Development of Hypertension and Kidney Hypertrophy in Transgenic Mice Overexpressing ARAP1 Gene in the Kidney

Deng-Fu Guo; Isabelle Chenier; Julie L. Lavoie; John S.D. Chan; Pavel Hamet; Johanne Tremblay; Xiang Mei Chen; Donna H. Wang; Tadashi Inagami

From the Research Centre (D-F.G., I.C., J.L.L., J.S.D.C., P.H., J.T.), Centre hospitalier de l’Université de Montréal, Hôtel-Dieu, Quebec, Canada; Department of Nephrology (X.M.C.), General Hospital of the People’s Liberation Army, Beijing, People’s Republic of China; Department of Medicine, Neuroscience, and Cell & Molecular Biology Program (D.H.W.), Michigan State University, East Lansing; and the Department of Biochemistry (T.I.), School of Medicine, Vanderbilt University, Nashville, Tenn.

Correspondence to Deng-Fu Guo, Research Centre, Centre hospitalier de l’Université de Montréal, Hôtel-Dieu, Pavillon Masson, 3850 Saint Urbain St, Montreal, Quebec, Canada H2W 1T8. E-mail guod{at}magellan.umontreal.ca

Angiotensin II regulates blood pressure via activation of the type 1 receptor. We previously identified a novel angiotensin II type 1 receptor–associated protein and demonstrated that it promotes receptor recycling to the plasma membrane. To delineate the pathophysiological function of the ARAP1 in the kidneys, we generated transgenic mice that overexpress rat ARAP1 cDNA specifically in proximal tubules and tested the hypothesis that proximal tubule-specific overexpression of ARAP1 causes hypertension. Two lines of male transgenic mice, 650 and 670, displayed kidney-specific transgene expression. Systolic blood pressure was significantly elevated by &20 to 25 mm Hg in these lines of mice at 20 weeks of age compared with their nontransgenic litter mates. Urine volume, but not water intake, was significantly decreased in both lines compared with nontransgenic controls. The kidney/body weight ratio was significantly increased in both lines compared with their nontransgenic litter mates at 12 and 20 weeks of age. In contrast, no difference was observed in the ratio of brain, spleen, heart, and testis to body weight between male transgenic and nontransgenic animals. Inhibitions of the renin–angiotensin system completely normalized the systolic blood pressure of transgenic mice. Moreover, low salt intake prevented the development of hypertension, whereas high salt intake exacerbated the increase in blood pressure in transgenic mice. Therefore, our data show that proximal tubule-specific overexpression of ARAP1 leads to hypertension, suggesting that renal ARAP1 plays an important role in the regulation of blood pressure and renal function via activation of the intrarenal renin–angiotensin system.

Key Words: animals, transgenic • gene expression

Related Article:

Does Angiotensin Receptor Recycling Regulate Blood Pressure?

Abraham P. Provoost
Hypertension 2006 48: 370-371. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				A. Jadhav, E. Torlakovic, and J. F. Ndisang Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats Am J Physiol Renal Physiol, March 1, 2009; 296(3): F521 - F534. [Abstract] [Full Text] [PDF]

				J. L. Cook, R. N. Re, D. L. deHaro, J. M. Abadie, M. Peters, and J. Alam The Trafficking Protein GABARAP Binds to and Enhances Plasma Membrane Expression and Function of the Angiotensin II Type 1 Receptor Circ. Res., June 20, 2008; 102(12): 1539 - 1547. [Abstract] [Full Text] [PDF]

				V. Seyrantepe, A. Hinek, J. Peng, M. Fedjaev, S. Ernest, Y. Kadota, M. Canuel, K. Itoh, C. R. Morales, J. Lavoie, et al. Enzymatic Activity of Lysosomal Carboxypeptidase (Cathepsin) A Is Required for Proper Elastic Fiber Formation and Inactivation of Endothelin-1 Circulation, April 15, 2008; 117(15): 1973 - 1981. [Abstract] [Full Text] [PDF]

				M. Mogi, M. Iwai, and M. Horiuchi Emerging Concepts of Regulation of Angiotensin II Receptors: New Players and Targets for Traditional Receptors Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2532 - 2539. [Abstract] [Full Text] [PDF]

				A. P. Provoost Does Angiotensin Receptor Recycling Regulate Blood Pressure? Hypertension, September 1, 2006; 48(3): 370 - 371. [Full Text] [PDF]